in

Mixed results for Moderna mRNA flu vaccine trial

flu shot

Credit: Unsplash/CC0 Public Domain

US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine.


Posted by Editor

Porsche Design Races on Ice

Porsche Design Races on Ice

The crypto comeback: Here's what's driving it, according to Bernstein

Bitcoin rises despite U.S. crackdown, as crypto market gains $84 billion in value